Entrada Ventures
SelectiveFiled to raiseSanta Barbara, CASales & marketing tech, Biotech & pharma, Consumer apps & internetLast fund filed 2022
4 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Entrada Ventures II-AFiled to raise in 2022, with no closing reported yet. | 2022 | $100M | $0 | 0 |
| Entrada Ventures IIFiled to raise in 2022, with no closing reported yet. | 2022 | $100M | $0 | 0 |
| Entrada Ventures I | October 2019 | $20M | $20M | 98 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
7 partners are named across this firm’s filings, 4 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Eric HallNot on the current fund | Slowing | Biotech & pharma, Consumer apps & internet | 4 |
Categories of Entrada Ventures’s own portfolio companies, based on 6 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Bonfire Ventures | 1 | INVOCA |
| Edison Partners | 1 | Lead Intelligence |
| The Column Group | 1 | RAPT Therapeutics |
| Upfront Ventures | 1 |
| 1 |
| Eric Kanowsky | Slowing | Cybersecurity | 3 | 1 |
| Alexander Fang | Quiet | None listed | 7 | 0 |
| Brian Coryat | Quiet | None listed | 2 | 0 |
| Jason Spievak | Quiet | Sales & marketing tech, Food & agriculture | 6 | 0 |
| Julie McNamaraNot on the current fund | Quiet | None listed | 2 | 0 |
| Karen DavisNot on the current fund | Quiet | None listed | 1 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Entrada Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| INVOCA |
| Westlake Biopartners | 1 | RAPT Therapeutics |
A shared board seat: a company where filings name a Entrada Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.